Which hedge funds own PRAX? PRAXIS PRECISION MEDICINES I, Q2 2026 13F holders
65 tracked hedge funds disclosed a position in PRAX (PRAXIS PRECISION MEDICINES I) in their Q2 2026 13F filings, worth $3.1bn in total. The largest holder by portfolio weight is Cormorant Asset Management, LP at 11.0% of its book. 18 opened a new position this quarter: Atika Capital Management LLC, Seven Fleet Capital Management LP, Polar Capital Holdings Plc, Readystate Asset Management LP. 13 exited: Ally Bridge Group (NY) LLC, RA Capital Management, L.P., Tetragon Partners GP Ltd.
- 65
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 18
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 13
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $136m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $152m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $3.1bn
- Combined value Sum of the holders' reported positions in the security.
- 5.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ally Bridge Group (NY) LLC | 10.5% | $10.6m |
| RA Capital Management, L.P. | 1.3% | $120m |
| Tetragon Partners GP Ltd | 1.0% | $5.1m |
| CTC Alternative Strategies, Ltd. | 0.7% | $298k |
| Prelude Capital Management, LLC | 0.2% | $2.9m |
| Persistent Asset Partners Ltd | 0.1% | $364k |
| AlphaGrep UK Ltd | 0.1% | $365k |
| Braidwell LP | 0.1% | $3.2m |
| Fox Run Management, L.L.C. | 0.07% | $385k |
| ExodusPoint Capital Management, LP | 0.05% | $4.7m |
| Centiva Capital, LP | 0.02% | $484k |
| Trexquant Investment LP | 0.02% | $2.1m |
| Hudson Bay Capital Management LP | 0.0% | $528k |
Ownership over time
Who discovered PRAX first? Beta
The run: Q1 2025 → Q2 2026, +784%
| Cormorant Asset Management, LP high conviction | Q1 2024 | 5.0% | +18.5 pts |
| Exome Asset Management LLC high conviction | Q2 2025 | – | +17.9 pts |
| Soleus Capital Management, L.P. | Q2 2024 | 3.4% | +13.2 pts |
| Perceptive Advisors LLC high conviction | Q3 2024 | 1.3% | +11.9 pts |
| B Group, Inc. high conviction | Q2 2025 | 0.6% | +8.7 pts |
| HighVista Strategies LLC | Q2 2025 | 0.6% | +6.2 pts |
| Ikarian Capital, LLC | Q1 2025 | 1.8% | +5.2 pts |
| Silverarc Capital Management, LLC | Q4 2024 | 1.3% | +4.7 pts |
| Tri Locum Partners LP | Q1 2025 | 1.6% | +4.5 pts |
| Logos Global Management LP high conviction | Q2 2025 | – | +4.2 pts |
| PFM Health Sciences, LP | Q1 2024 | 0.5% | +2.8 pts |
| Ally Bridge Group (NY) LLC high conviction | Q1 2024 | 3.3% | +1.8 pts |
| 5AM Venture Management, LLC | Q1 2024 | 2.4% | +0.5 pts |
| Sphera Funds Management Ltd. | Q1 2024 | 1.3% | +0.5 pts |
| Venrock Adviser, LLC high conviction | Q1 2024 | 3.2% | −0.9 pts |
| Sio Capital Management, LLC | Q1 2025 | 1.3% | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.